Sökning: onr:"swepub:oai:DiVA.org:uu-442888" > Mortality outcomes ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 16652naa a2201453 4500 | |
001 | oai:DiVA.org:uu-442888 | |
003 | SwePub | |
008 | 210521s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4428882 URI |
024 | 7 | a https://doi.org/10.1038/s41467-021-22446-z2 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Axfors, Cathrineu Uppsala universitet,Obstetrisk och reproduktiv hälsoforskning,Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.4 aut0 (Swepub:uu)catax386 |
245 | 1 0 | a Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials |
264 | c 2021-04-15 | |
264 | 1 | b Springer Nature,c 2021 |
338 | a electronic2 rdacarrier | |
500 | a Correction in: Nature Communications, year: 2021, volume: 12, Article number: 3001, DOI: 10.1038/s41467-021-23559-1 Shared first authorship: Cathrine Axfors and Andreas M. Schmitt. | |
520 | a Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine and chloroquine on survival in COVID-19 from all currently available RCT evidence, published and unpublished. We present a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients (protocol: https://osf.io/QESV4/). We systematically identified unpublished RCTs (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, Cochrane COVID-registry up to June 11, 2020), and published RCTs (PubMed, medRxiv and bioRxiv up to October 16, 2020). All-cause mortality has been extracted (publications/preprints) or requested from investigators and combined in random-effects meta-analyses, calculating odds ratios (ORs) with 95% confidence intervals (CIs), separately for hydroxychloroquine and chloroquine. Prespecified subgroup analyses include patient setting, diagnostic confirmation, control type, and publication status. Sixty-three trials were potentially eligible. We included 14 unpublished trials (1308 patients) and 14 publications/preprints (9011 patients). Results for hydroxychloroquine are dominated by RECOVERY and WHO SOLIDARITY, two highly pragmatic trials, which employed relatively high doses and included 4716 and 1853 patients, respectively (67% of the total sample size). The combined OR on all-cause mortality for hydroxychloroquine is 1.11 (95% CI: 1.02, 1.20; I-2=0%; 26 trials; 10,012 patients) and for chloroquine 1.77 (95%CI: 0.15, 21.13, I-2=0%; 4 trials; 307 patients). We identified no subgroup effects. We found that treatment with hydroxychloroquine is associated with increased mortality in COVID-19 patients, and there is no benefit of chloroquine. Findings have unclear generalizability to outpatients, children, pregnant women, and people with comorbidities. Hydroxychloroquine and chloroquine have been investigated as a potential treatment for Covid-19 in several clinical trials. Here the authors report a meta-analysis of published and unpublished trials, and show that treatment with hydroxychloroquine for patients with Covid-19 was associated with increased mortality, and there was no benefit from chloroquine. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
700 | 1 | a Schmitt, Andreas M.u Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland.;Univ Basel, Dept Med Oncol, Basel, Switzerland.4 aut |
700 | 1 | a Janiaud, Perrineu Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland.4 aut |
700 | 1 | a van't Hooft, Jannekeu Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.;Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands.4 aut |
700 | 1 | a Abd-Elsalam, Sheriefu Tanta Univ, Fac Med, Trop Med & Infect Dis Dept, Tanta, Egypt.4 aut |
700 | 1 | a Abdo, Ehab F.u Assiut Univ, Fac Med, Trop Med & Gastroenterol Dept, Assiut, Egypt.4 aut |
700 | 1 | a Abella, Benjamin S.u Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA.4 aut |
700 | 1 | a Akram, Javedu Univ Hlth Sci, Dept Internal Med, Lahore, Punjab, Pakistan.4 aut |
700 | 1 | a Amaravadi, Ravi K.u Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.;Univ Penn, Dept Med, Philadelphia, PA 19104 USA.4 aut |
700 | 1 | a Angus, Derek C.u Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA USA.;Univ Pittsburgh, UPMC Hlth Syst Off Healthcare Innovat, Med Ctr, Pittsburgh, PA USA.4 aut |
700 | 1 | a Arabi, Yaseen M.u King Saud Bin Abdulaziz Univ Hlth Sci, Intens Care Dept, Riyadh, Saudi Arabia.;King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.4 aut |
700 | 1 | a Azhar, Shehnooru Univ Hlth Sci, Dept Publ Hlth, Lahore, Punjab, Pakistan.4 aut |
700 | 1 | a Baden, Lindsey R.u Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.4 aut |
700 | 1 | a Baker, Arthur W.u Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Belkhir, Leilau Catholic Univ Louvain, Infect Dis Dept, Clin Univ St Luc, Brussels, Belgium.4 aut |
700 | 1 | a Benfield, Thomasu Copenhagen Univ Hosp, Ctr Res & Disrupt Infect Dis, Dept Infect Dis, Hvidovre, Denmark.4 aut |
700 | 1 | a Berrevoets, Marvin A. H.u Elisabeth Tweesteden Hosp, Dept Internal Med, Tilburg, Netherlands.4 aut |
700 | 1 | a Chen, Cheng-Pinu Minist Hlth & Welf, Dept Infect Dis, Taoyuan Gen Hosp, Taoyuan, Taiwan.4 aut |
700 | 1 | a Chen, Tsung-Chiau Minist Hlth & Welf, Dept Internal Med, Taichung Hosp, Taichung, Taiwan.4 aut |
700 | 1 | a Cheng, Shu-Hsingu Minist Hlth & Welf, Dept Infect Dis, Taoyuan Gen Hosp, Taoyuan, Taiwan.4 aut |
700 | 1 | a Cheng, Chien-Yuu Minist Hlth & Welf, Dept Infect Dis, Taoyuan Gen Hosp, Taoyuan, Taiwan.4 aut |
700 | 1 | a Chung, Wei-Shengu Minist Hlth & Welf, Dept Internal Med, Taichung Hosp, Taichung, Taiwan.4 aut |
700 | 1 | a Cohen, Yehuda Z.u Sanofi, Bridgewater, NJ USA.4 aut |
700 | 1 | a Cowan, Lisa N.u Sanofi, Bridgewater, NJ USA.4 aut |
700 | 1 | a Dalgard, Olavu Akershus Univ Hosp, Dept Infect Dis, Div Med, Lorenskog, Norway.;Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.4 aut |
700 | 1 | a de Almeida e Val, Fernando F.u Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.4 aut |
700 | 1 | a de Lacerda, Marcus V. G.u Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.;FIOCRUZ AM, Inst Leonidas & Maria Deane ILMD, Manaus, Amazonas, Brazil.4 aut |
700 | 1 | a de Melo, Gisely C.u Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.;Univ Estado Amazonas, Manaus, Amazonas, Brazil.4 aut |
700 | 1 | a Derde, Lennieu Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.;Univ Med Ctr Utrecht, Intens Care Ctr, Utrecht, Netherlands.4 aut |
700 | 1 | a Dubee, Vincentu Angers Univ Hosp, Infect & Trop Dis Dept, Angers, France.4 aut |
700 | 1 | a Elfakir, Anissau Ividata Life Sci, Levallois Perret, France.4 aut |
700 | 1 | a Gordon, Anthony C.u Imperial Coll London, Dept Surg & Canc Anaesthet Pain Med & Intens Care, London, England.;Imperial Coll Healthcare NHS Trust, London, England.4 aut |
700 | 1 | a Hernandez-Cardenas, Carmen M.u Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Crit Care Dept, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Hills, Thomasu Med Res Inst New Zealand, Wellington, New Zealand.;Auckland City Hosp, Auckland, New Zealand.4 aut |
700 | 1 | a Hoepelman, Andy I. M.u Univ Med Ctr Utrecht, Dept Infect Dis, Utrecht, Netherlands.4 aut |
700 | 1 | a Huang, Yi-Wenu Minist Hlth & Welf, Dept Internal Med, Chang Hua Hosp, Changhua, Taiwan.4 aut |
700 | 1 | a Igau, Brunou Sanofi, Bridgewater, NJ USA.4 aut |
700 | 1 | a Jin, Ronghuau Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China.4 aut |
700 | 1 | a Jurado-Camacho, Felipeu Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Crit Care Dept, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Khan, Khalid S.u Univ Granada, Hosp Real, Dept Prevent Med & Publ Hlth, Ave Hosp, Granada, Spain.4 aut |
700 | 1 | a Kremsner, Peter G.u Univ Tubingen, Inst Trop Med, Tubingen, Germany.;Ctr Rech Med Lambarene, Lambarene, Gabon.;German Ctr Infect Res, Partner Site Tubingen, Tubingen, Germany.4 aut |
700 | 1 | a Kreuels, Bennou Univ Med Ctr Hamburg Eppendorf, Dept Med, Div Trop Med, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Div Infect Dis, Hamburg, Germany.;Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany.4 aut |
700 | 1 | a Kuo, Cheng-Yuu Minist Hlth & Welf, Dept Internal Med, Pingtung Hosp, Pingtung, Taiwan.4 aut |
700 | 1 | a Le, Thuy4 aut |
700 | 1 | a Lin, Yi-Chunu Minist Hlth & Welf, Dept Infect Dis, Taoyuan Gen Hosp, Taoyuan, Taiwan.4 aut |
700 | 1 | a Lin, Wu-Puu Minist Hlth & Welf, Dept Internal Med, Taipei Hosp, New Taipei, Taiwan.4 aut |
700 | 1 | a Lin, Tse-Hungu Minist Hlth & Welf, Dept Internal Med, Chang Hua Hosp, Changhua, Taiwan.4 aut |
700 | 1 | a Lyngbakken, Magnus Nakremu Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.;Akershus Univ Hosp, Div Med, Lorenskog, Norway.4 aut |
700 | 1 | a McArthur, Colinu Med Res Inst New Zealand, Wellington, New Zealand.;Auckland City Hosp, Auckland, New Zealand.;Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.4 aut |
700 | 1 | a McVerry, Bryan J.u Univ Pittsburgh, Dept Med, Pittsburgh, PA USA.4 aut |
700 | 1 | a Meza-Meneses, Patriciau Hosp Reg Alta Especialidad Ixtapaluca, Ixtapaluca, Mexico.4 aut |
700 | 1 | a Monteiro, Wuelton M.u Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.;Univ Estado Amazonas, Manaus, Amazonas, Brazil.4 aut |
700 | 1 | a Morpeth, Susan C.u Middlemore Hosp, Auckland, New Zealand.4 aut |
700 | 1 | a Mourad, Ahmadu Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA.4 aut |
700 | 1 | a Mulligan, Mark J.u NYU Grossman Sch Med, Dept Microbiol, New York, NY USA.;NYU Grossman Sch Med, Dept Internal Med, Div Infect Dis & Immunol, New York, NY USA.4 aut |
700 | 1 | a Murthy, Srinivasu Univ British Columbia, Sch Med, Vancouver, BC, Canada.4 aut |
700 | 1 | a Naggie, Susannau Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Narayanasamy, Shantiu Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Nichol, Alistairu Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.;Alfred Hlth, Dept Intens Care, Melbourne, Vic, Australia.;St Vincents Univ Hosp, Dept Anesthesia & Intens Care, Dublin, Ireland.;Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland.4 aut |
700 | 1 | a Novack, Lewis A.u Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.4 aut |
700 | 1 | a O'Brien, Sean M.u Duke Univ, Dept Biostat & Bioinformat, Med Ctr, Durham, NC USA.;Duke Clin Res Inst, Durham, NC USA.4 aut |
700 | 1 | a Okeke, Nwora Lanceu Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Perez, Lenau Excelya, Montpellier, France.4 aut |
700 | 1 | a Perez-Padilla, Rogeliou Inst Nacl Enfermedades Resp Ismael Casio Villegas, Dept Smoking & COPD, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Perrin, Laurentu Sanofi, Montpellier, France.4 aut |
700 | 1 | a Remigio-Luna, Arantxau Inst Nacl Enfermedades Resp Ismael Casio Villegas, Dept Smoking & COPD, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Rivera-Martinez, Norma E.u Hosp Reg Alta Especialidad Oaxaca, Oaxaca, Oaxaca, Mexico.4 aut |
700 | 1 | a Rockhold, Frank W.u Duke Univ, Dept Biostat & Bioinformat, Med Ctr, Durham, NC USA.;Duke Clin Res Inst, Durham, NC USA.4 aut |
700 | 1 | a Rodriguez-Llamazares, Sebastianu Inst Nacl Enfermedades Resp Ismael Casio Villegas, Dept Smoking & COPD, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Rolfe, Robertu Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Rosa, Rossanau UnityPoint Hlth, Des Moines, IA USA.4 aut |
700 | 1 | a Rosjo, Helgeu Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.;Akershus Univ Hosp, Div Res & Innovat, Lorenskog, Norway.4 aut |
700 | 1 | a Sampaio, Vanderson S.u Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.;Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.4 aut |
700 | 1 | a Seto, Todd B.u Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.;Queens Med Ctr, Honolulu, HI USA.4 aut |
700 | 1 | a Shahzad, Muhammadu Univ Hlth Sci, Dept Pharmacol, Lahore, Punjab, Pakistan.4 aut |
700 | 1 | a Soliman, Shaimaau Menoufia Univ, Publ Hlth & Community Med, Menoufia, Egypt.4 aut |
700 | 1 | a Stout, Jason E.u Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Thirion-Romero, Ireriu Inst Nacl Enfermedades Resp Ismael Casio Villegas, Dept Smoking & COPD, Ciudad De Mexico, Mexico.4 aut |
700 | 1 | a Troxel, Andrea B.u NYU Grossman Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA.4 aut |
700 | 1 | a Tseng, Ting-Yuu Minist Hlth & Welf, Dept Internal Med, Taichung Hosp, Taichung, Taiwan.4 aut |
700 | 1 | a Turner, Nicholas A.u Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Ulrich, Robert J.u NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA.4 aut |
700 | 1 | a Walsh, Stephen R.u Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.4 aut |
700 | 1 | a Webb, Steve A.u Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.;St John God Hosp, Subiaco, WA, Australia.4 aut |
700 | 1 | a Weehuizen, Jesper M.u Univ Med Ctr Utrecht, Dept Infect Dis, Utrecht, Netherlands.4 aut |
700 | 1 | a Velinova, Mariau PRA Hlth Sci, Groningen, Netherlands.4 aut |
700 | 1 | a Wong, Hon-Laiu Minist Hlth & Welf, Dept Internal Med, Keelung Hosp, Keelung, Taiwan.4 aut |
700 | 1 | a Wrenn, Rebekahu Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.4 aut |
700 | 1 | a Zampieri, Fernando G.u HCor Hosp Coracao, Res Inst, Sao Paulo, Brazil.;BRICNet Brazilian Res Intens Care Network, Res Inst, Sao Paulo, Brazil.;IDor Res Inst, Sao Paulo, Brazil.4 aut |
700 | 1 | a Zhong, Wuu Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Emergency Drug, Beijing, Peoples R China.4 aut |
700 | 1 | a Moher, Davidu Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada.4 aut |
700 | 1 | a Goodman, Steven N.u Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.;Stanford Univ, Sch Med, Stanford, CA 94305 USA.;Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA 94305 USA.4 aut |
700 | 1 | a Ioannidis, John P. A.u Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.;Stanford Univ, Sch Med, Stanford, CA 94305 USA.;Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA 94305 USA.;Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.;Berlin Inst Hlth, Meta Res Innovat Ctr Berlin METRIC B, Berlin, Germany.4 aut |
700 | 1 | a Hemkens, Lars G.u Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.;Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland.;Berlin Inst Hlth, Meta Res Innovat Ctr Berlin METRIC B, Berlin, Germany.4 aut |
710 | 2 | a Uppsala universitetb Obstetrisk och reproduktiv hälsoforskning4 org |
773 | 0 | t Nature Communicationsd : Springer Natureg 12:1q 12:1x 2041-1723 |
856 | 4 | u https://doi.org/10.1038/s41467-021-22446-zy Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1556288/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://www.nature.com/articles/s41467-021-22446-z.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-442888 |
856 | 4 8 | u https://doi.org/10.1038/s41467-021-22446-z |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy